These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 33277732)

  • 1. The challenges and applications of nanotechnology against bacterial resistance.
    Lei Z; Karim A
    J Vet Pharmacol Ther; 2021 May; 44(3):281-297. PubMed ID: 33277732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanotechnology as a therapeutic tool to combat microbial resistance.
    Pelgrift RY; Friedman AJ
    Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1803-15. PubMed ID: 23892192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A mechanistic perspective on targeting bacterial drug resistance with nanoparticles.
    Khorsandi K; Keyvani-Ghamsari S; Khatibi Shahidi F; Hosseinzadeh R; Kanwal S
    J Drug Target; 2021 Nov; 29(9):941-959. PubMed ID: 33703979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. From Nano to Micro: using nanotechnology to combat microorganisms and their multidrug resistance.
    Natan M; Banin E
    FEMS Microbiol Rev; 2017 May; 41(3):302-322. PubMed ID: 28419240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emergence of a Potent Multidrug Efflux Pump Variant That Enhances Campylobacter Resistance to Multiple Antibiotics.
    Yao H; Shen Z; Wang Y; Deng F; Liu D; Naren G; Dai L; Su CC; Wang B; Wang S; Wu C; Yu EW; Zhang Q; Shen J
    mBio; 2016 Sep; 7(5):. PubMed ID: 27651364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nano-Strategies to Fight Multidrug Resistant Bacteria-"A Battle of the Titans".
    Baptista PV; McCusker MP; Carvalho A; Ferreira DA; Mohan NM; Martins M; Fernandes AR
    Front Microbiol; 2018; 9():1441. PubMed ID: 30013539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metal nanoparticles against multi-drug-resistance bacteria.
    Mishra A; Pradhan D; Halder J; Biswasroy P; Rai VK; Dubey D; Kar B; Ghosh G; Rath G
    J Inorg Biochem; 2022 Dec; 237():111938. PubMed ID: 36122430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metal nanobullets for multidrug resistant bacteria and biofilms.
    Chen CW; Hsu CY; Lai SM; Syu WJ; Wang TY; Lai PS
    Adv Drug Deliv Rev; 2014 Nov; 78():88-104. PubMed ID: 25138828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coping with antibiotic resistance: combining nanoparticles with antibiotics and other antimicrobial agents.
    Allahverdiyev AM; Kon KV; Abamor ES; Bagirova M; Rafailovich M
    Expert Rev Anti Infect Ther; 2011 Nov; 9(11):1035-52. PubMed ID: 22029522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel Antibacterial Strategies for Combating Bacterial Multidrug Resistance.
    Xu XL; Kang XQ; Qi J; Jin FY; Liu D; Du YZ
    Curr Pharm Des; 2019; 25(44):4717-4724. PubMed ID: 31642769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanoantibiotics: A Novel Rational Approach to Antibiotic Resistant Infections.
    Engin AB; Engin A
    Curr Drug Metab; 2019; 20(9):720-741. PubMed ID: 31385767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of Nanocarrier Systems in Drug Delivery for Overcoming Multi-Drug Resistance in Bacteria.
    Qumsani AT
    Pak J Biol Sci; 2023 Feb; 26(3):131-137. PubMed ID: 37480270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New Roads Leading to Old Destinations: Efflux Pumps as Targets to Reverse Multidrug Resistance in Bacteria.
    Spengler G; Kincses A; Gajdács M; Amaral L
    Molecules; 2017 Mar; 22(3):. PubMed ID: 28294992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanobiotechnological Approaches Against Multidrug Resistant Bacterial Pathogens: An Update.
    Shaikh S; Shakil S; Abuzenadah AM; Rizvi SM; Roberts PM; Mushtaq G; Kamal MA
    Curr Drug Metab; 2015; 16(5):362-70. PubMed ID: 26419545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanotechnology-driven strategies to enhance the treatment of drug-resistant bacterial infections.
    Zhang J; Liu M; Guo H; Gao S; Hu Y; Zeng G; Yang D
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2024; 16(3):e1968. PubMed ID: 38772565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liposomes as Antibiotic Delivery Systems: A Promising Nanotechnological Strategy against Antimicrobial Resistance.
    Ferreira M; Ogren M; Dias JNR; Silva M; Gil S; Tavares L; Aires-da-Silva F; Gaspar MM; Aguiar SI
    Molecules; 2021 Apr; 26(7):. PubMed ID: 33918529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanomaterials as drug delivery systems with antibacterial properties: current trends and future priorities.
    Khorsandi K; Hosseinzadeh R; Sadat Esfahani H; Keyvani-Ghamsari S; Ur Rahman S
    Expert Rev Anti Infect Ther; 2021 Oct; 19(10):1299-1323. PubMed ID: 33755503
    [No Abstract]   [Full Text] [Related]  

  • 18. Folic acid-modified mesoporous silica nanoparticles with pH-responsiveness loaded with Amp for an enhanced effect against anti-drug-resistant bacteria by overcoming efflux pump systems.
    Chen X; Liu Y; Lin A; Huang N; Long L; Gang Y; Liu J
    Biomater Sci; 2018 Jun; 6(7):1923-1935. PubMed ID: 29850668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploiting nanotechnology to overcome tumor drug resistance: Challenges and opportunities.
    Kirtane AR; Kalscheuer SM; Panyam J
    Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1731-47. PubMed ID: 24036273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efflux Pump Inhibitors: A Novel Approach to Combat Efflux-Mediated Drug Resistance in Bacteria.
    Wang Y; Venter H; Ma S
    Curr Drug Targets; 2016; 17(6):702-19. PubMed ID: 26424403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.